Author Information
Ammarin Thakkinstian is affiliated with the Section for Clinical Epidemiology and Biostatistics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand. His research primarily focuses on various aspects of clinical epidemiology and biostatistics, contributing significantly to the understanding of disease mechanisms, treatment efficacy, and economic evaluations in healthcare.Research Contributions
In 2022, Ammarin Thakkinstian published several influential papers covering a wide range of topics. His research includes exploring the causal relationship between excess body weight and cardiovascular events, evaluating the efficacy of HER2-targeted therapies in HER2-positive breast cancer, and conducting economic evaluations of influenza vaccination in elderly and healthcare workers. Additionally, he has investigated the adverse health outcomes associated with hormonal contraceptive use, the cost-benefit of direct oral anticoagulants in preventing venous thromboembolism, and the causal pathways between fetuin-A and kidney function. His work on the immunogenicity of the ChAdOx1 nCoV-19 vaccine against various COVID-19 variants in kidney transplant recipients and healthy volunteers has also garnered attention. Furthermore, Thakkinstian has contributed to the understanding of the preventive effects of antiplatelet therapy on myocardial infarction, validated prognostic models for chronic kidney disease in type 2 diabetes patients, and addressed methodological issues in meta-analyses of economic evaluation studies.Aliases
Ammarin Thakkinstian is also known by the aliases A Thakkinstian and A. Thakkinstian.Publication and Citation Metrics
| Metric |
Value |
| Citation Count |
11593 |
| h-index |
59 |
| Paper Count |
380 |
